Product
Ledipasvir/Sofosbuvir
1 clinical trial
1 indication
Indication
Hepatitis C Virus InfectionClinical trial
A Long Term Follow-up Registry for Adolescent and Pediatric Subjects Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection TrialsStatus: Terminated, Estimated PCD: 2023-01-06